The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease.

作者: Yuan-Yuan Jiang , Wei Xiao , Mao-Xiang Zhu , Zhi-Hua Yang , Xiu-Jie Pan

DOI: 10.1016/J.RMED.2012.08.018

关键词:

摘要: Summary Background Previous research has shown that innate immune system was more important than the acquired in pathogenesis of COPD. LL-37 is only human cathelicidin identified so far. As an integral part system, besides antibacterial activity, its chemotactic damage repairing, influencing apoptosis and cytotoxicity are attracting people's attention. The aim present study to evaluate role Methods ELISA immunohistochemistry were applied investigate expression induced sputum lung tissue COPD patients. Bronchial epithelial cell (BEP2D) alveolar (A549) treated with synthesis polypeptide in vitro assess inflammation apoptosis. Results We found increased levels patients associated airflow limitation, health status exercise tolerance expressing intensity both airway district pulmonary alveoli area group significantly compared control group. Through stimulation by CSE LPS, bronchial cell. can promote releasing inflammatory factor IL-8 induce Conclusion This suggested may play be a possible novel therapeutic target

参考文章(37)
Ole Sørensen, Kristina Arnljots, Jack B. Cowland, Dorothy F. Bainton, Niels Borregaard, The Human Antibacterial Cathelicidin, hCAP-18, Is Synthesized in Myelocytes and Metamyelocytes and Localized to Specific Granules in Neutrophils Blood. ,vol. 90, pp. 2796- 2803 ,(1997) , 10.1182/BLOOD.V90.7.2796
Caroline Owen, Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease. ,vol. 3, pp. 253- 268 ,(2008) , 10.2147/COPD.S2089
Isao Nagaoka, Satoko Hirota, François Niyonsaba, Michimasa Hirata, Yoshiyuki Adachi, Hiroshi Tamura, Didier Heumann, Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-α by Blocking the Binding of LPS to CD14+Cells The Journal of Immunology. ,vol. 167, pp. 3329- 3338 ,(2001) , 10.4049/JIMMUNOL.167.6.3329
G. Sandra Tjabringa, Jamil Aarbiou, Dennis K. Ninaber, Jan Wouter Drijfhout, Ole E. Sørensen, Niels Borregaard, Klaus F. Rabe, Pieter S. Hiemstra, The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor Journal of Immunology. ,vol. 171, pp. 6690- 6696 ,(2003) , 10.4049/JIMMUNOL.171.12.6690
Robert P. Schleimer, Innate Immune Responses and Chronic Obstructive Pulmonary Disease Proceedings of the American Thoracic Society. ,(2012)
Holownia A, Chyczewska E, Noparlik J, Braszko Jj, Mroz Rm, Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. Journal of Physiology and Pharmacology. ,vol. 58, pp. 453- 460 ,(2007)
TERENCE A. R. SEEMUNGAL, GAVIN C. DONALDSON, ANGSHU BHOWMIK, DONALD J. JEFFRIES, JADWIGA A. WEDZICHA, Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. ,vol. 161, pp. 1608- 1613 ,(2000) , 10.1164/AJRCCM.161.5.9908022
Kris De Smet, Roland Contreras, Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnology Letters. ,vol. 27, pp. 1337- 1347 ,(2005) , 10.1007/S10529-005-0936-5
Jack B. Cowland, Anders H. Johnsen, Niels Borregaard, hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules FEBS Letters. ,vol. 368, pp. 173- 176 ,(1995) , 10.1016/0014-5793(95)00634-L